[1]¶Å ¾²ª¬ª©,Ô¬ Óª¬ª©¡÷ªª,½½¨ÈÙª¬ª©ªª,µÈ.CD10ÔÚ¼××´ÏÙÖ×Áö×éÖ¯Öеıí´ï¼°¼ì²âÁÙ´²ÒâÒ媬*[J].ÉÂÎ÷ҽѧÔÓÖ¾,2019,(2):248-251£¬255.
¡¡DU Jing,YUAN Yong,LU Jianrong,et al.Expression and significance of CD10 in thyroid neoplasms[J].,2019,(2):248-251£¬255.

µã»÷¸´ÖÆ

CD10ÔÚ¼××´ÏÙÖ×Áö×éÖ¯Öеıí´ï¼°¼ì²âÁÙ´²ÒâÒ媬*

·ÖÏíµ½£º

²Î¿¼ÎÄÏ×/References:

\[1\] Raposo TP,Sueca CM.CD10 inhibits cell motility but expression is associated with advanced stage disease in colorectal cancer\[J\].Exp Mol Pathol,2018,104£¨3£©£º190ª²198.ª¤
\[2\] Ogawa H,Iwaya K.Expression of CD10 by stromal cells during colorectal tumor development\[J\].Human Pathology,2002,33(8)£º806ª²811.ª¤
\[3\] Maguerª²Satta V,Besancon R, Bachelardª²Cascales E.Concise review£ºneutral endopeptidase (CD10)£ºa multifaceted environment actor in stem cells£¬physiological mechanisms,and cancer\[J\].Stem Cells,2011,29(3)£º389ª²396.ª¤
\[4\] Zou WW,Xu SP.Galangin inhibits the cell progression and induces cell apoptosis through activating PTEN and Caspaseª²3 pathways in retinoblastoma\[J\].Biomed Pharmacother,2017,97£º851ª²863.ª¤
\[5\] Sumitomo M,Shen R,Walburg M,ª«et alª«.Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling\[J\].Clin Invest,2000,106£º1399ª²1407.ª¤
\[6\] ¡¼JP3¡½Iwaya K,Ogawa H,Izumi M,ª«et alª«.Stromal expression of CD10 in invasive breast carcinoma£ºa new predictor of clinical outcome\[J\].Virchows Arch,2002,440(6)£º589ª²593.¡¼JP¡½ª¤
\[7\] Kaur M,Verma S,Gupta R,ª«et alª«.CD10 expression pattern in prostatic adenocarcinoma: Elucidation of differences between Gleason¡¯s grades\[J\].Malays J Pathol,2018,40£¨1£©£º57ª²60.ª¤
\[8\] Hu GM,Chen HP,Wang CF,ª«et alª«.Expression of CD10 in fibrous histiocytoma and its significance\[J\].Zhonghua Bing Li Xue Za Zhi,2018,47£¨2£©£º130ª²131.ª¤
\[9\] Tomoda C,Kushima R,Takeuti E,ª«et alª«.CD10 exp ressi on is useful in the diagnosis of f olli cular carcinoma and folli cular variant of papillary thy roid carcinoma \[J\] . Thyroid,2003,13(3)£º291.¡¼ZK)¡½ª¤
\[10\] Yegen G,Demir MA,Ertan Y,ª«et alª«. Can CD10 be used as a diagnostic marker in thyroid pathology?\[J\]. Virchows Arch,2009,454£º101ª²105.ª¤
\[11\] Mokhtari M,Ameri F.Diagnostic value of CDª²10 marker in differentiation of papillary thyroid carcinoma from benign thyroid lesions\[J\].Adv Biomed Res,2014,3:206.ª¤
\[12\] Lloyd RV,Osamura RY,Kloppel G,ª«et alª«.World Health Organization Classification of Tumors of Endocrine Organs\[M\].Lyon.France£ºIARC Press,2016.ª¤
\[13\] Lydia D,Adriana HL.CD10 expression in pancreatic endocrine tumors£ºcorrelation with prognostic factors and survival\[J\].Hum Pathol,2006,37£¨7£©£º802ª²808. ª¤
\[14\] Junna O,Takeshi N.Expression of CD10 predicts tumor progression and unfavorable prognosis in malignant melanoma\[J\].Journal of the American Academy of Dermatology,2011,65£¨6£©£º1152ª²1160.ª¤
\[15\] Kyuichi K,Daniel B.Tumoral CD10 expression correlates with highª²grade histology and increases risk of recurrence in patients with stage I lung adenocarcinoma\[J\].Lung Cancer,2015,89£¨3£©£º329ª²336.ª¤
\[16\] Fujita S,Taniguchi H,Yao T,ª«et alª«.Multiª²institutional study of risk factors of liver metastasis from colorectal cancer£ºcorrelation with CD10 expression\[J\].Int J Colorectal Dis,2010,25£º681ª²686.ª¤
\[17\] Dall¡¯Era MA,True LD.Differential expression of CD10 in prostate cancer and its clinical implication\[J\].BMC Urol,2007,7£º3.ª¤
\[18\] ËÚÁ¬Ðã.½áÖ±³¦°©×éÖ¯¼äÖÊϸ°ûÖÐCD10µ°°×µÄ±í´ï±ä»¯¼°ÁÙ´²ÒâÒå\[J\].ɽ¶«Ò½Ò©,2013,53(47)£º84ª²85.ª¤
\[19\] Huang WB,Zhou XJ.CD10ª²positive stromal cells in gastric carcinoma: correlation with invasion and metastasis\[J\].Jpn J Clin Oncol,2005,35(5)£º245ª²250.ª¤
\[20\] Makretsov NA,Hayes M.Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis,estrogen receptor negativity, and high grade\[J\].Mod Pathol,2007,20(1)£º84ª²89.ª¤
\[21\] Kondo T,Nakazawa T,Murata S,ª«et alª«.Stromal elastosis in papillary thyroid carcinomas\[J\].Hum Pathol,2005,36£º474ª²479. ª¤
\[22\] Goodman OB Jr,Febbraio M,Simantov R,ª«et alª«.Neprilysin inhibits angiogenesis via proteolysis of fibroblast growth factorª²2\[J\].J Biol Chem,2006,281£º33597ª²33605.ª¤
\[23\] Deniz K,Cohan G,Okten T.Antiª²CD10 (56C6) expression in soft tissue sarcomas pathol \[J\].Res Pract, 2012,208£º281ª²285.ª¤
\[24\] ¹È •D,Íõæ­ö©,Áõ ÎÄ,µÈ.CD10¼ø±ðÕï¶Ï×Ó¹¬ÄÚĤ¼äÖÊÈâÁöµÄϵͳÆÀ¼Û\[J\].ÏÖ´úÖ×Áöҽѧ,2011,19£¨11£©£º2301ª²2304.ª¤